Prothex, Inc / Drais Pharmaceuticals, Inc. Email Format

Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees

Drais Pharmaceuticals, Inc. is a venture capital supported drug development company with an exciting new business model. Through strong relationships with Astellas Pharma Inc. and our venture capital investors - InterWest Partners, Sutter Hill Ventures, and Astellas Venture Management LLC, we have created multiple virtual companies to enable the development of interesting novel compounds in a variety of therapeutic areas. Our focus is on early stage development through proof of concept. Our business model relies on a small internal team who provide drug development services to those virtual companies via vendors and CROs. Our internal experts are able to move compounds rapidly through key development milestones and decision points, thus de-risking programs early in development. Prior to forming Drais, the management team founded AkaRx, Inc., successfully guiding their lead compound into Phase 2 proof of concept and negotiating an option and eventual sale of the company to Eisai Inc in 2010. As big pharma is rethinking its approach to drug development and risk management, Drais is providing a unique alternative. For more information and career opportunities, please visit: http://www.draispharma.com.

Sign up for free to view info

Company overview Employee directory